← TrialMatch
HomeTrials

Splinting vs Exercise in De Quervain's Tenosynovitis

De Quervain's disease is a painful tenosynovitis of the abductor pollicis longus and extensor pollicis brevis muscle tendons located in the first dorsal compartment. The primary treatment for De Quervain's disease is conservative; surgical intervention is rarely required. Currently, there is no standardized treatment p

Condition(s)Splints, Exercise Therapy, De Quervains Tenosynovitis, Pain Management, Ultrasonographic
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryDe Quervain's disease is a painful tenosynovitis of the abductor pollicis longus and extensor pollicis brevis muscle tendons located in the first dorsal compartment. The primary treatment for De Quervain's disease is conservative; surgical intervention is rarely required. Currently, there is no standardized treatment protocol supported by strong, up-to-date evidence. The aim of this study is to compare the effectiveness of a static hand-wrist resting splint and exercise therapy in the conservative treatment of De Quervain's tenosynovitis. Patients will be evaluated in terms of pain levels, functional/symptom status, hand-finger strength, pressure pain threshold (PPT), tendon cross-sectional area measured by ultrasound, and the presence of effusion findings (semiquantitative; 0-3), and pati
Who can participateInclusion Criteria: * Adults aged between 18 and 65 years Patients experiencing wrist pain and tenderness for less than 3 months and clinically diagnosed with acute or subacute De Quervain's tenosynovitis Visual Analog Scale (VAS) pain score ≥ 3 Exclusion Criteria: * History of trauma Wrist fractures Local infection Presence of rheumatologic diseases (e.g., rheumatoid arthritis, psoriatic arthritis) Presence of symptomatic hand osteoarthritis Continuous use of nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids Receipt of physical therapy for the hand or wrist within the past 3 months Corticosteroid injection into the hand or wrist within the past 3 months Diagnosed with significant neurological disorders (e.g., upper motor neuron disease) Presence of uncontrolled systemic dis
Ages18 Years to 65 Years
SexAll
Lead sponsorKonya Beyhekim Training and Research Hospital
LocationsKonya, Turkey (Türkiye)
Start date2025-05-29
NCT IDNCT06995534
Official listinghttps://clinicaltrials.gov/study/NCT06995534

🔍 Search all trials →